Melatonin Neurim

Melatonin, the active ingredient in Melatonin Neurim, is a melatonin receptor agonist presented as an oral formulation for oral use. It is used to help regulate the sleep‑wake cycle in adults experiencing insomnia, jet lag, or circadian rhythm sleep disorders.

GNH USA supplies Melatonin Neurim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for sleep‑related therapeutics across global markets. Customers benefit from consistent batch release and regulatory support.

Melatonin Neurim acts on melatonin receptors to address sleep‑related disorders. - Insomnia: helps reduce sleep onset latency and improve sleep maintenance in adults. - Jet lag: assists in adjusting the circadian clock after rapid time‑zone travel, reducing daytime sleepiness. - Circadian rhythm sleep disorders: supports synchronization of the internal clock to a normal sleep‑wake schedule. - Delayed sleep phase disorder: facilitates earlier sleep onset by advancing the circadian phase. - Shift work disorder: may improve sleep quality for workers on rotating schedules.

Adverse reactions may occur with melatonin use.

Common Side Effects: - Headache: mild to moderate pain often resolving without intervention. - Dizziness: transient sensation of light‑headedness. - Daytime sleepiness: residual drowsiness after nighttime dosing. - Nausea: mild gastrointestinal discomfort. - Vivid dreams: unusual or intense dreaming experiences. - Mild abdominal discomfort: occasional stomach upset.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe rash: potentially indicating a hypersensitivity response. - Mood changes: depression or increased anxiety. - Hallucinations: visual or auditory disturbances. - Worsening insomnia: paradoxical sleep disruption. - Cardiac arrhythmia: rare irregular heart rhythm events.

Before initiating therapy, consider the following safety measures. - Assess sleep patterns: evaluate underlying causes of insomnia. - Avoid operating machinery: monitor for daytime drowsiness before engaging in tasks requiring alertness. - Age considerations: use caution in elderly patients due to increased sensitivity. - Review concomitant medications: potential interactions with central nervous system depressants. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Melatonin may interact with other substances; monitor accordingly.

Major Interactions (Avoid): - Combined with CNS depressants: may enhance sedative effect. - Concurrent use with anticoagulants: possible increased bleeding risk (theoretical). - Interaction with immunosuppressants: may affect melatonin metabolism.

Moderate Interactions (Monitor Closely): - Alcohol: may increase drowsiness. - Caffeine: may counteract sleep‑promoting effect. - Antidepressants (SSRIs): may alter melatonin levels.